Chaudhury et al. and Tye et al. present two opposing
viewpoints in regards to the mechanisms behind depression and depressive-like
behavior. I was surprised to find that both these papers were published in
the same issue of Nature in 2012. Whereas Chaudhury et al. establishes two links—one
between the excitation of VTA dopaminergic neuron phasic firing patterns and a susceptibility
to a depression-like phenotype as well as one between the inhibition of the
same VTA neuronal projections to the nucleus accumbens (validated by a social
defeat behavioral paradigm and sucrose preference test)—Tye et al. utilizes a
tail-suspension test as a CMS paradigm as well as a sucrose preference test to
claim that a reduced modulation of dopamine cell firing in the VTA causes
depressive-like symptoms whereas the inhibition of VTA dopaminergic projection
neurons to the nucleus accumbens increases depressive phenotypes. I would assert
that both arguments are backed with adequate research models and extensive
methodology sections, (using similar optogenetic, chemogenetic, and
electrophysiology techniques to derive their conclusions), and hence both are sound and demonstrate validity. That being said, the question isn’t which
paper is “right”, but rather, how can we use the combination of the two to
further develop a model for how depression works. It’s a well known fact that
depression is one of the most complex psychological phenomena, as it manifests
itself in such a multitude of ways across the board. Furthermore, it’s often
accompanied with various forms of anxiety—whether it be social, GAD, PTSD, etc.—and
each individual prognosis expresses different symptomatic behavior. After
reading the two review articles on Scientific American as well, it becomes
clear that the Chaudhury et al. repeated social defeat paradigm attempts to
induce a stress model that is objectively more severe than the chronic mild
stress model used by Tye et al. It brought me to thinking about how although we
often assume the mesolimbic dopamine system is modulated by more or less the
same pathway, every different type of stress model causes varied downstream
pathway effects, and we still have ways to go in the field before we truly understand depression in the brain.
April 13 Papers (Buffington et. al, Reber et. al) I found this week’s papers to be quite novel in that they both proposed potential treatments for neurodevelopmental or psychiatric disorders that target bacterial or microbial abnormalities and how these give rise to certain behavioral and physical symptoms associated with the disorders. I thought this was a very unusual yet interesting approach, and as I have not previously studied the gut-brain axis, these papers offered me a fresh perspective on researching psychiatric and neurodevelopmental disorders. They were also unconventional in their focus of the physical symptoms that often accompany mental disorders, as this is not something that I have seen many other papers touch upon very much. Particularly, I was surprised by the Reber et al paper’s focus on the link between psychiatric disorders and inflammation in organs other than the brain, such as the colon, and the Buffington et al paper’s description of a relationship between ...
Comments
Post a Comment